.
MergerLinks Header Logo

Announced

Pfizer to acquire Amplyx Pharmaceuticals.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Pending

Pharmaceuticals

Friendly

United States

Domestic

Majority

Single Bidder

Private

pharma

Acquisition

Synopsis

Edit

Pfizer, an American multinational pharmaceutical corporation, agreed to acquire Amplyx Pharmaceuticals, a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases. Financial terms were not disclosed. “We are deeply committed to helping patients suffering from infectious diseases, continuously seeking opportunities to build our portfolio of anti-infective therapies. We’ve already invested in assets that, if approved, could help address drug-resistant bacterial infections and critical viral infections; with this acquisition, we look forward to progressing the development of a novel anti-fungal as well,” Angela Lukin, Pfizer Hospital Global President.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US